Airsonett
Ängelholm
About Airsonett
Airsonett is a medical device company that develops treatments for allergic asthma and eczema. The Air4 product from Airsonett is a non-invasive home medical device that relies on patented Temperature-controlled Laminar Airflow technology (TLA). Allergens and other airborne irritants are significantly reduced from the patient's breathing zone during rest and sleep after treatment with the Airsonett Air4. Airsonett Air4 helps many patients with allergic asthma and atopic eczema, in Sweden and the UK.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $9.7M
- Last round: Series Unknown (Jul 2022)
- Website: airsonett.com
- Phone: +46 (0)431 40 25 30
Industries & Categories
Health Care, Information Technology, Medical, Service Industry
Social Profiles
Canonical: https://fsome.com/organization/airsonett-210437 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.